nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to Referees
|
|
|
|
22 |
4 |
p. 255-256 |
artikel |
2 |
Chinese- and French-Manufactured Immediate-Release Glucophage® Bioequivalence: A Randomized, Open-Label, Crossover Study
|
Hu, Chaoying |
|
|
22 |
4 |
p. 301-309 |
artikel |
3 |
Clinical Validation of the Covariates Pharmacokinetic Model for Propofol in an Adult Population
|
Hawthorne, Christopher |
|
|
22 |
4 |
p. 289-300 |
artikel |
4 |
Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation
|
Ono, Ryohei |
|
|
22 |
4 |
p. 281-288 |
artikel |
5 |
Novel Strategies for the Treatment of COVID-19
|
McCarthy, Matthew W. |
|
|
22 |
4 |
p. 257-262 |
artikel |
6 |
Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions
|
Luo, Hong-Yu |
|
|
22 |
4 |
p. 311-320 |
artikel |
7 |
Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome
|
Yang, Shuangyan |
|
|
22 |
4 |
p. 271-279 |
artikel |
8 |
Risk Factors for Septic Shock After Irinotecan-Containing Chemotherapy: An Exploratory Case-Control Study
|
Umemiya, Maki |
|
|
22 |
4 |
p. 263-269 |
artikel |